Neuroscience is the Next Oncology

| April 1, 2018 | 0 Comments

by Michael D. Ehlers, MD, PhD

Dr. Ehlers is with Biogen in Cambridge, Massachusetts.

Innov Clin Neurosci. 2018;15(3–4):15–16

Funding: No funding was received for the preparation of this article.

Disclosures: Dr. Ehlers is an employee and shareholder at Biogen Inc. in Cambridge, Massachusetts.

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Category: Commentary, Past Articles, Trial Methodology

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.